Image (A3e28863 853a 49f5 9036 0b5b8367ca8d 01)
Liothyronine Sodium Tablet
Product Images NDC 70771-1606
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Liothyronine Sodium (NDC 70771-1606). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Zydus Lifesciences Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Label (A3e28863 853a 49f5 9036 0b5b8367ca8d 02)
Label (A3e28863 853a 49f5 9036 0b5b8367ca8d 03)
This is the description of a medication named Liothyronine which comes in tablet form. It consists of liothyronine sodium equivalent to 25 megs of liothyronine. The tablets should be stored in a tight container between 16 to 30°C. It is important to use safety measures when it is being dispensed. The package is child-resistant. The manufacturer of this medication is Zydus.*
Label (A3e28863 853a 49f5 9036 0b5b8367ca8d 04)
This is a drug package of Liothyronine Sodium Tablets. Each tablet contains fothyronine sodium, USP equivalent to 50 meg o ithyronine. The package has 100 tablets and is only for prescription use. The usual dosage information is mentioned. The product must be stored between 15° and 0°C. It is manufactured by Cata Healthcare Ltd., India.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
